Medicine and Dentistry
Acute Myeloid Leukemia
100%
Neoplasm
76%
Acute Leukemia
62%
Myelodysplastic Syndrome
39%
Disease
37%
NPM1
30%
Karyotype
26%
De Novo Acute Myeloid Leukemia
24%
Diagnosis
23%
Myeloproliferative Neoplasm
23%
Pediatrics
22%
Morphology
21%
Lymphoid Leukemia
21%
Flow Cytometry
21%
Leukemia
18%
Dysplasia
16%
Myeloid Malignancy
16%
Acute Lymphoblastic Leukemia
15%
Hematopathology
15%
Overall Survival
15%
Immunophenotyping
13%
Janus Kinase
12%
Anaplastic Large Cell Lymphoma
11%
Genetic Screening
11%
Minimal Residual Disease
10%
Malignant Neoplasm
9%
Cytopenia
9%
Hematologic Malignancy
9%
Hematopoiesis
9%
Megakaryocyte
8%
Acute Myelogenous Leukemia
8%
Down Syndrome
8%
Allele
8%
Posttransplant Lymphoproliferative Disease
8%
Myeloid metaplasia
8%
Precursor
7%
Gene Frequency
7%
Next Generation Sequencing
7%
Estrogen Receptor
7%
Non Small Cell Lung Cancer
6%
B Cell
6%
Follicular Lymphoma
6%
ASXL1
6%
Disease Course
6%
Gene Mutation
5%
Exon
5%
Myeloid Sarcoma
5%
Mutation Rate
5%
Cancer Therapy
5%
Health Care Cost
5%
Keyphrases
Mixed-phenotype Acute Leukemia
43%
Acute Myeloid Leukemia
39%
Myeloid Neoplasms
18%
De Novo Acute Myeloid Leukemia
17%
Acute Leukemia
16%
Bone Marrow Pathology
16%
Nucleophosmin 1 (NPM1)
13%
Overall Survival
12%
Post-transplant Lymphoproliferative Disorder
12%
Acute Leukemia of Ambiguous Lineage
12%
Myeloid Malignancies
12%
Immunophenotypic Profile
11%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
11%
B-lymphoblastic Leukemia
10%
World Health Organization Classification
10%
Hematological Malignancies
9%
Working Diagnosis
9%
TP53 mutation
9%
Myelodysplastic Syndrome
9%
Immunophenotyping
9%
Pediatric
9%
Minimal Residual Disease
9%
Complex Karyotype
8%
Acute Lymphoblastic Leukemia
8%
Clinical Characterization
8%
Acute Myeloid Leukemia with Myelodysplasia-related Changes
8%
Mutant Allele Frequency
8%
T-AML
8%
Gene mutation
7%
Bone Marrow
7%
Cytogenetic Abnormalities
7%
Non-acute
7%
Acute Undifferentiated Leukemia
7%
Peripheral Blood
6%
Flow Cytometry
6%
Hematopoietic Stem Cells
6%
Classification System
6%
Leukemia
5%
NPM1 mutation
5%
Dysplasia
5%
Therapy-related
5%
Antigen Expression
5%
Genomic Landscape
5%
Molecular Analysis
5%
Genetic Testing
5%
Human Hematopoiesis
5%
Myeloproliferative Neoplasms
5%
Biochemistry, Genetics and Molecular Biology
Myeloid
91%
Cytogenetics
27%
Karyotype
23%
Overall Survival
23%
Genetics
19%
NPM1
15%
ASXL1
13%
T Cell
13%
Molecular Genetics
10%
Flow Cytometry
9%
Gene Mutation
8%
Germline
8%
Germ Cell
8%
KRAS
7%
CCAAT Enhancer Binding Protein Alpha
7%
RUNX1
6%
Morphology
6%
Next Generation Sequencing
6%
Transcription
6%
Hematopoiesis
6%
Janus Kinase
5%
Gene Frequency
5%
Essential Thrombocythaemia
5%
Trisomy 8
5%
Precursor
5%
Epigenetics
5%
Progenitor Cell
5%
IDH1
5%
